NEPHROCARE HEALTH SERV L Share Price

NEPHROCARE HEALTH SERV L Share Price

NSE: NEPHROPLUS
|
Healthcare
|
S Cap
₹ 692.05
-₹0.65 (-0.09%)
1D
Last updated 03 Sep, 2026, 10:49 IST

NEPHROCARE HEALTH SERV L Share Price Today

As of 3 Sep 2026, NEPHROCARE HEALTH SERV L share price is ₹692.05. The stock opened at ₹693.30, compared to its previous close of ₹692.70. During today's trading session, NEPHROCARE HEALTH SERV L share price moved in the range of ₹686.10 to ₹699.50, with an average price of ₹692.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹446.00 and a high of ₹769.75. On the performance front, NEPHROCARE HEALTH SERV L share price has increased by 18.85% over the last six months and is up 46.99% on a year-on-year basis.


₹686.10
0.09% down today
₹699.50
1D LOW
1D HIGH

NEPHROCARE HEALTH SERV L Returns Calculator


Circuit
L
H
₹554.20
₹831.20
52-week
L
H
₹446.00
₹769.75

About NEPHROCARE HEALTH SERV L

NEPHROCARE HEALTH SERV L Share Price
ISIN
INE428V01029
Sector Market Cap
₹ 6,932.54 Cr

Nephrocare Health Services Limited, formerly Nephrocare Health Services Pvt Ltd, is an India-based company. The Company is primarily engaged in the business of providing dialysis and sale of related healthcare services and products. The Company offers comprehensive dialysis care through the network of clinics from diagnosis to treatment and wellness programs including hemodialysis, home and mobile dialysis, supported by a pharmacy. It has a network of approximately 490 clinics, with 43 clinics internationally across the Philippines, Uzbekistan and Nepal. Its subsidiaries include Nephrocare Health Services Central Asia FE LLC, Nephrocare Health Services International Pte. Ltd, Nephrocare Health Services Nepal Private Limited, and others.

NEPHROCARE HEALTH SERV L Financial Highlights

  • Revenue: NEPHROCARE HEALTH SERV L reported revenue of ₹1,023.36 crore in FY26 vs ₹769.91 crore in FY25. It showed an increase of 32.92% on a yearly basis.
  • Operating Profit: NEPHROCARE HEALTH SERV L reported an operating profit of ₹97.47 crore in FY26 vs ₹87.44 crore in FY25. It showed an increase of 11.47% on a year-on-year basis.
  • Net Profit: NEPHROCARE HEALTH SERV L reported a net profit of ₹76.84 crore in FY26 vs ₹67.10 crore in FY25. It showed an increase of 14.52% on a yearly basis.

NEPHROCARE HEALTH SERV L Quarterly Result Highlights

  • NEPHROCARE HEALTH SERV L reported revenue of ₹289.21 crore in Jun 2026, compared with ₹277.19 crore in Mar 2026, representing an increase of 4.34% on a quarter-on-quarter (QoQ) basis.
  • NEPHROCARE HEALTH SERV L reported an operating profit of ₹41.03 crore in Jun 2026, compared with ₹33.22 crore in Mar 2026, representing an increase of 23.51% on a quarter-on-quarter (QoQ) basis.
  • NEPHROCARE HEALTH SERV L reported a profit of ₹31.97 crore in Jun 2026, compared with ₹30.37 crore in Mar 2026, reflecting an increase of 5.27% on a QoQ basis.
  • The earnings per share (EPS) of NEPHROCARE HEALTH SERV L stood at ₹8.48 during Jun 2026.
Know more
Promoters
63.85%
FII
8.78%
Other DII
5.85%
Retail and other
18.32%
Mutual funds
3.20%
Foreign institutions - FII
FII shareholding by period
Jul 20250.00%
Dec 20259.30%
Mar 20269.94%
Jun 20268.78%
Mkt Cap Cr
6,932.54

P/E
81.66

P/B
6.22

ROE
6.88%

D/E
0.01

ROCE
13.18%

Div. Yield
0.00%

EPS(TTM)
-0.89
Turnover
0.57

EV/EBITDA
25.79

Net Margin
-1.65%

Op. Margin
16.59%

ROA
5.79%

Quick Ratio
4.15

Curr. Ratio
4.40
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Nephrocare Health Services outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Nephrocare Health Services appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Nephrocare Health Services revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,25,998.0057.6913.2220.48%0.3217.27%692.920.23%0.66103.81
MANIPAL HEALTH ENTERPRI L93,280.00102.925.6810.59%0.469.51%0.000.00%0.000.00
Max Healthcare96,743.7066.409.0013.42%0.0912.97%91.840.20%0.277.37
Fortis Healthcare68,991.9064.456.9710.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare66,430.20183.2014.508.48%0.3110.10%53.530.23%0.435.20
Narayana Hrudayalaya39,297.6048.128.6617.76%0.7611.42%127.100.23%0.7624.77
Global Health39,162.5070.379.8114.05%0.0615.26%149.240.03%0.7318.46
Dr. Lal Path Labs32,118.7058.7912.8020.13%0.0825.56%147.341.07%0.9130.45
KRISHNA INST OF MED SCI L31,878.50162.728.4410.74%0.637.99%93.540.00%0.426.52
Poly Medicure18,086.4057.805.8210.37%0.0812.71%301.170.20%0.4833.15

NEPHROCARE HEALTH SERV L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹998.85₹755.81₹566.16₹437.29
Other Income₹24.51₹14.10₹8.57₹5.96
Total Revenue₹1,023.36₹769.92₹574.72₹443.26
Total Expenses₹922.79₹682.48₹541.56₹451.85
Profit Before Tax₹97.47₹87.44₹33.16-₹8.59
Tax₹20.63₹20.34-₹1.97₹3.20
Profit After Tax₹76.84₹67.10₹35.13-₹11.79
EPS - Basic₹8.48₹8.28₹4.55-₹67.95
EPS - Diluted₹8.10₹8.01₹4.40-₹67.95

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹97.47₹87.44₹33.16-₹8.59
Income before WC changes₹265.70₹180.48₹113.35₹59.97
Change in Assets-₹88.05-₹69.45-₹59.42-₹66.55
Change in Liabilities₹82.41₹25.28₹26.42₹13.23
Change in WC-₹5.64-₹44.17-₹33.00-₹53.32
Cash flow from Operations₹232.58₹135.35₹72.28₹11.27
Cash flow from Investing-₹410.44-₹125.07-₹50.66-₹78.21
Cash flow from Financing₹157.11₹54.37₹26.74₹59.97
Total Cash Flow-₹20.75₹64.65₹48.36-₹4.49
Cash (Start of the year)₹125.82₹61.15₹14.06₹18.55
Cash (End of the year)₹123.89₹125.82₹61.15₹14.06

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹631.70₹451.10₹415.98₹341.98
Current Assets₹839.17₹545.36₹390.03₹324.25
Total Assets₹1,470.87₹996.46₹806.02₹666.23
Current Liabilities₹299.41₹283.90₹242.59₹174.61
Net Current Asset₹539.76₹261.46₹147.45₹149.64
Non-Current Liabilities₹54.96₹128.45₹149.72₹102.99
Equity Capital₹1,116.49₹584.11₹413.71₹388.63
Total Equity & Liabilities₹1,470.87₹996.46₹806.02₹666.23

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹629.74₹543.60₹436.23₹386.11
Other Income₹15.43₹15.63₹7.80₹5.09
Total Revenue₹645.18₹559.23₹444.03₹391.20
Total Expenses₹648.95₹513.87₹443.82₹404.08
Profit Before Tax-₹3.77₹45.36₹0.22-₹12.88
Tax₹4.29₹11.12-₹3.67₹2.59
Profit After Tax-₹8.06₹34.24₹3.88-₹15.47
EPS - Basic-₹0.89₹4.23₹0.50-₹29.86
EPS - Diluted-₹0.89₹4.09₹0.50-₹29.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹3.77₹45.36₹0.22-₹12.88
Income before WC changes₹117.41₹106.22₹60.81₹44.57
Change in Assets-₹39.93-₹52.40-₹21.96-₹45.57
Change in Liabilities₹73.29₹22.47₹20.30₹8.19
Change in WC₹33.36-₹29.92-₹1.66-₹37.38
Cash flow from Operations₹132.90₹79.73₹53.34₹11.14
Cash flow from Investing-₹298.75-₹103.52-₹19.26-₹74.71
Cash flow from Financing₹255.67₹26.02-₹35.54₹63.39
Total Cash Flow₹89.82₹2.23-₹1.46-₹0.18
Cash (Start of the year)₹3.85₹1.62₹3.08₹3.26
Cash (End of the year)₹93.68₹3.85₹1.62₹3.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹492.33₹425.36₹408.02₹364.30
Current Assets₹642.72₹331.25₹256.55₹282.59
Total Assets₹1,135.05₹756.61₹664.57₹646.89
Current Liabilities₹150.64₹154.90₹185.03₹156.85
Net Current Asset₹492.08₹176.36₹71.53₹125.73
Non-Current Liabilities₹13.50₹59.71₹75.33₹93.39
Equity Capital₹970.91₹542.01₹404.22₹396.65
Total Equity & Liabilities₹1,135.05₹756.61₹664.57₹646.89
* All values are in INR Crore
Qty
Bid
3
692.15
6
692.1
4
692.05
5
692
3
691.95
Ask
Qty
692.5
2
692.8
3
692.85
8
692.9
7
692.95
49
Bid Total: 21
Ask Total: 69
Buy orders: 23%
Sell orders: 77%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
52.3
Neutral

ATR (14)
24.77
Neutral

STOCH(9,6)
50.27
Neutral

STOCH RSI (14)
65.29
Neutral

ADX(9)
20.9
Bearish

UO(9)
42.75
Neutral

ROC(12)
-0.28
Bearish

WillR(14)
-55.28
Neutral
Period
Simple value
Exponential vaue

5D
688.61
689.99

10D
688.96
689.98

20D
691.09
688.78

50D
676.12
677.61

100D
647.04
671.93
Volume trend — traded volume by day
3 Sep0L
2 Sep1L
1 Sep4L
31 Aug2L
28 Aug0L
27 Aug1L
Average1L
Compare against other stocks
NEPHROCARE HEALTH SERV L Share Price
NEPHROCARE HEALTH SERV L
Healthcare
Add Stock
Add Another

NEPHROCARE HEALTH SERV L Share Price FAQs